These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 38415729)
41. [Dermatologic manifestations of the antiphospholipid syndrome]. Francès C; Barete S; Soria A Rev Med Interne; 2012 Apr; 33(4):200-5. PubMed ID: 22078802 [TBL] [Abstract][Full Text] [Related]
42. [Case series and clinical analysis of 14 cases of catastrophic antiphospholipid syndrome]. Gu JY; Lu C; Shi H; Yang CD Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1033-1038. PubMed ID: 30562777 [TBL] [Abstract][Full Text] [Related]
44. Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome. Bala MM; Celinska-Lowenhoff M; Szot W; Padjas A; Kaczmarczyk M; Swierz MJ; Undas A Cochrane Database Syst Rev; 2020 Oct; 10(10):CD012169. PubMed ID: 33045766 [TBL] [Abstract][Full Text] [Related]
45. [The antiphospholipid syndrome, an update]. Alonso Santor JE; Inglada Galiana L; Pérez Paredes G An Med Interna; 2007 May; 24(5):242-8. PubMed ID: 17907891 [TBL] [Abstract][Full Text] [Related]
46. Renal artery stenosis in hypertensive patients with antiphospholipid (Hughes) syndrome: outcome following anticoagulation. Sangle SR; D'Cruz DP; Abbs IC; Khamashta MA; Hughes GR Rheumatology (Oxford); 2005 Mar; 44(3):372-7. PubMed ID: 15572388 [TBL] [Abstract][Full Text] [Related]
48. Aortitis is an under-recognized manifestation of antiphospholipid syndrome: A case report and literature review. Escoda T; George J; Jarrot PA; Jean R; Mazodier K; Sanderson F; Poullin P; Saby L; Jourde-Chiche N; Kaplanski G; Chiche L Lupus; 2022 May; 31(6):744-753. PubMed ID: 35341372 [TBL] [Abstract][Full Text] [Related]
49. Catastrophic antiphospholipid syndrome presenting as fever of unknown origin. Al-Beladi FI Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):110-3. PubMed ID: 22237230 [TBL] [Abstract][Full Text] [Related]
50. Renal involvement in antiphospholipid syndrome. de Azevedo FVA; Maia DG; de Carvalho JF; Rodrigues CEM Rheumatol Int; 2018 Oct; 38(10):1777-1789. PubMed ID: 29730854 [TBL] [Abstract][Full Text] [Related]
51. Cutaneous microvascular occlusion syndrome as the first manifestation of catastrophic lupus-associated antiphospholipid antibody syndrome: a case report. Hosseini NS; Babaei S; Rahimi H; Gheissari A; Sedaghat B; Pourmahdi-Boroujeni M; Abtahi-Naeini B J Med Case Rep; 2023 Aug; 17(1):375. PubMed ID: 37605287 [TBL] [Abstract][Full Text] [Related]
52. [Antiphospholipid antibody syndrome]. Chakoutio V; Ries F Bull Soc Sci Med Grand Duche Luxemb; 2009; (1):27-43. PubMed ID: 19514174 [TBL] [Abstract][Full Text] [Related]
53. Diagnosis and management of the antiphospholipid syndrome. Chaturvedi S; McCrae KR Blood Rev; 2017 Nov; 31(6):406-417. PubMed ID: 28784423 [TBL] [Abstract][Full Text] [Related]
54. Management of antiphospholipid syndrome. Uthman I; Noureldine MHA; Ruiz-Irastorza G; Khamashta M Ann Rheum Dis; 2019 Feb; 78(2):155-161. PubMed ID: 30282668 [TBL] [Abstract][Full Text] [Related]
55. Retinal arterial and venous obstruction as the first manifestation of an antiphospholipid antibody syndrome. Pérez-Crespo A; Gutiérrez-Ortiz C Arch Soc Esp Oftalmol (Engl Ed); 2021 Jul; 96(7):380-383. PubMed ID: 34217476 [TBL] [Abstract][Full Text] [Related]